BIOMAT Database Logo BIOMAT Database Logo

[Scalp cooling for chemotherapy-induced alopecia]. 2011

Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Medisch Centrum Alkmaar, afd. Oncologie, Alkmaar, the Netherlands. manon.komen@mca.nl

Alopecia is a very common side effect of cytostatic therapy and is considered one of the most emotionally distressing effects. To prevent alopecia scalp cooling is currently used in some indications in medical oncology in 59 hospitals in the Netherlands. The success of scalp cooling depends on various factors such as type of chemotherapy, dose, infusion time, number of treatment cycles and combinations of drugs. In general, scalp cooling is well tolerated. The reported side-effects are headache, coldness, dizziness and sometimes claustrophobia. An increase in the risk of scalp metastases has not been demonstrated. Proceeding from the South Netherlands Comprehensive Cancer Centre a national working group is put together in order to draw up a national guideline for chemotherapy-induced alopecia.

UI MeSH Term Description Entries
D007036 Hypothermia, Induced Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000505 Alopecia Absence of hair from areas where it is normally present. Alopecia, Androgenetic,Baldness,Male Pattern Baldness,Pseudopelade,Alopecia Cicatrisata,Alopecia, Male Pattern,Androgenetic Alopecia,Androgenic Alopecia,Baldness, Male Pattern,Female Pattern Baldness,Hair Loss,Pattern Baldness,Alopecia Cicatrisatas,Alopecia, Androgenic,Alopecias, Androgenic,Androgenic Alopecias,Baldness, Female Pattern,Baldness, Pattern,Hair Losses,Loss, Hair,Losses, Hair,Male Pattern Alopecia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012535 Scalp The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL). Scalps
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Scalp cooling: management option for chemotherapy-induced alopecia.
January 2014, British journal of nursing (Mark Allen Publishing),
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention.
February 2006, Annals of oncology : official journal of the European Society for Medical Oncology,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Reducing chemotherapy-induced alopecia with scalp cooling.
October 2012, Clinical advances in hematology & oncology : H&O,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Scalp cooling to prevent chemotherapy-induced alopecia.
January 2020, Anais brasileiros de dermatologia,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia.
January 2023, Journal of the American Academy of Dermatology,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Scalp Cooling: The Prevention of Chemotherapy-Induced Alopecia
.
August 2017, Clinical journal of oncology nursing,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Management of Chemotherapy-Induced Alopecia With Scalp Cooling.
March 2018, Journal of oncology practice,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Chemotherapy, Alopecia, and Scalp Cooling Systems.
March 2022, Actas dermo-sifiliograficas,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia.
June 2022, Oncology nursing forum,
Marion M C Komen, and Carolien H Smorenburg, and Corina J G van den Hurk, and J W R Hans Nortier
Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia.
December 1990, The Netherlands journal of medicine,
Copied contents to your clipboard!